What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News The USP15 Biological Thermostat: a Promising Novel Therapeutic Target in Cancer After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d’Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today publis News VHIR's director participates in the 5th Annual Conference of the Technological Platforms of Biomedical Research The director of Vall d'Hebron Research Institute (VHIR), Dr. Joan Comella, has participated in 5th Annual Conference of the Technological Platforms of Biomedical Research: Innovative Medicines, Nanomedicina, Sanitary Technology and Biotechnological Markets, Promoting the Open Innovation held in Barc News The Society of Critical Care Medicine awards VHIR's researchers A joint work of researchers from Vall d'Hebron Research Institute (VHIR) has received the '2012 Annual Cardiovascular Speciality award' for its outstanding research contributions to the Society of Critical Care Medicine. The abstract, entitled 'Innovative continous non invasive cuffless blood pressu News 5th SMD Integrated Diagnostic Workshop Cytology, Immunophenotype and cytogenetics Units of Hematology from Vall d'Hebron University Hospital organized on February 7 the Fifth Integrated Diagnostics Workshop Myelodysplastic Syndromes (MDS) of clinical cases.The fifth edition of the workshop, led by Dr Teresa Vallespí, member of the experi News Dr. Margarita Salas opens on March 9 the 1st edition of 'Women and Science' at VHIR VHIR will organize in March the first edition of the cycle 'Women and Science'. Structured in four meetings in four consecutive weeks, the opening session will take place on March 9 with the conference 'Woman and Science: my own experience' by Dr. Margarita Salas, who has dedicated all her life to s News VHIR's researchers participate in TVE's debate on inflammatory intestinal diseases The inflammatory intestinal diseases are increasing in the developed countries. To know for what reason and to be able to face them better, researchers from Vall d'Hebron Research Institute (VHIR) are studying the bacteria of the human intestine. To talk about it, Dr. Francisco Guarner, from the res News BMV course on Clinical Excellence in Cardiology During January 26th and 27th, more tan 200 cardiologists have visited Vall d’Hebron University Hospital (HUVH) to attend the 2nd edition of the "BMV course on Clinical Excellence in Cardiology". The BMV course is a joint initiative of the Services of Cardiology of HUVH, Hospital General Universitari News An international study with participation of Vall d'Hebron reveals RAS mutations associated to BRAF inhibitors The treatment of the melanoma with BRAF inhibitors has obtained big successes but it has taken as a not wished effect the development of secondary tumours, scaly carcinomas well differentiated and queratoacantomas. An international study reveals the high frequency of mutations of RAS in this type o News Running for stroke The Stroke Unit at Vall d'Hebron University Hospital (HUVH) and the neurovascular diseases group at Vall d’Hebron Research Institute (VHIR) team together to run the Half Marathon of Barcelona on February 26 and to raise funds for the research in silent strokes.The idea came from the Stroke Unit at H News Dr. Guarner explains the keys of the microbioma in the journal 'Publico' The project Human Genome sequenced the genetic information contained in 10% of the cells that form the human body. The remaining 90% aren't human cells but an authentic ecosystem of approximately hundred trillions of bacteria living in our body. They receive the name of microbioma, and science is di News An international study determines Firategrast's efficiency, an oral medicament for the treatment of the multiple sclerosis An international research in which have participated Vall d'Hebron Research Institute (VHIR) and the Center of Multiple sclerosis of Catalonia (CEM-Cat) determines that the therapy with firategrast, an oral medicament anti a4b-integrina, is effective in the treatment of the multiple sclerosis. The s News VHIR and CRG to collaborate in basic and clinical research projects The Centre for Genomic Regulation (CRG) and the Vall d'Hebron Research Institute (VHIR) have signed an agreement for the development of collaborative projects in basic and clinical research. One of the proposed focuses is research on rare genetic diseases.The agreement, signed by the directors of th News VHIR's research identifies a new suppressing gene of colorectal tumors The CIBBIM-Nanomedicine-Molecular Oncology group at Vall d'Hebron Research Institute (VHIR) has identified the role of a gene -the Myosina 1a or MYO1A- in the appearance of the colorectal cancer. What until now was known as a gene without too much importance and responsible of part of the internal s News VHIR's research proves why the sexual hormones diminish in diabetic and obese people The group of Diabetes and Metabolism at Vall d'Hebron Research Institute (VHIR) has determined for the first time a link between the inflammation of low degree, typical of the people with obesity and/or diabetes type II, and the low levels of the SHBG (sex hormone-binding globular) or transport prot News VHIR's research on microbiome, runner up of the Science Breakthrough of the Year 2011 Science's editors and news staff have selected one scientific Breakthrough of the Year 2011 and nine runners-up. This year's runners-up for Breakthrough of the Year highlight exciting developments in medicine, the history of the universe, human ancestry, and more. One of them is the microbiome resea News Bones Festes i Feliç Any Nou / Felices Fiestas y Feliz Año Nuevo / Season's Greetings and Happy New Year News Dr. Vila ranked as one of the top cited researchers worldwide in the field of Parkinson's disease Dr. Miquel Vila, head of the neurodegenerative diseases group at Vall d'Hebron Research Institute (VHIR), is ranked among top 100 researchers of the world in productivity and impact in the field of Parkinson's disease, according to a study published recently by the Journal of Parkinson's Disease. Th News Dr. Boada gives a lecture about Alzheimer at the University of Pittsburgh Dr. Mercè Boada, head of Alzheimer group at Vall d'Hebron Research Institute (VHIR) and medical director of Fundació ACE, was invited on December 8th by the University of Pittsburgh Alzheimer Disease Research Center and Western Psychiatric Institute and Clinic to lecture the Conference "Methodologi News 'Informe Semanal' TV show highlights the surgery of a fetus affected with spina bifida as one of the milestones of the year TVE's historical tv show 'Informe Semanal' highlighted in its last edition of December 17, the summary of the year, the surgery of a fetus affected with spina bifida with a pioneering technique in the world at Vall d'Hebron University Hospital after it was succesfully tested in sheep and the researc News New guide of use of Probiotics and Prebiotics Recently it has been published the new version of the guide of use of Probiotics and Prebiotics in gastroenterology in the web page of the World Gastroenterology Organization (WGO). In the production of the guide there has taken part a group of experts of the whole world presided by the Dr. Francisc Pagination First page « Previous page ‹ … Page 134 Page 135 Current page 136 Page 137 Page 138 … Next page › Last page »
